Galibier Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $986K | Buy |
2,432
+950
| +64% | +$385K | 0.3% | 27 |
|
|
2025
Q1 | $737K | Sell |
1,482
-119
| -7% | -$59.2K | 0.23% | 27 |
|
|
2024
Q4 | $833K | Hold |
1,601
| – | – | 0.24% | 25 |
|
|
2024
Q3 | $990K | Hold |
1,601
| – | – | 0.22% | 32 |
|
|
2024
Q2 | $885K | Hold |
1,601
| – | – | 0.22% | 34 |
|
|
2024
Q1 | $931K | Hold |
1,601
| – | – | 0.22% | 30 |
|
|
2023
Q4 | $850K | Hold |
1,601
| – | – | 0.22% | 26 |
|
|
2023
Q3 | $810K | Sell |
1,601
-64
| -4% | -$32.4K | 0.18% | 28 |
|
|
2023
Q2 | $869K | Hold |
1,665
| – | – | 0.2% | 29 |
|
|
2023
Q1 | $960K | Hold |
1,665
| – | – | 0.23% | 29 |
|
|
2022
Q4 | $917K | Hold |
1,665
| – | – | 0.19% | 28 |
|
|
2022
Q3 | $844K | Hold |
1,665
| – | – | 0.17% | 31 |
|
|
2022
Q2 | $905K | Hold |
1,665
| – | – | 0.17% | 30 |
|
|
2022
Q1 | $983K | Hold |
1,665
| – | – | 0.13% | 31 |
|
|
2021
Q4 | $1.11M | Hold |
1,665
| – | – | 0.16% | 27 |
|
|
2021
Q3 | $951K | Sell |
1,665
-500
| -23% | -$286K | 0.13% | 31 |
|
|
2021
Q2 | $1.09M | Hold |
2,165
| – | – | 0.15% | 29 |
|
|
2021
Q1 | $988K | Hold |
2,165
| – | – | 0.15% | 31 |
|
|
2020
Q4 | $1.01M | Sell |
2,165
-230
| -10% | -$107K | 0.17% | 26 |
|
|
2020
Q3 | $1.06M | Sell |
2,395
-450
| -16% | -$199K | 0.25% | 25 |
|
|
2020
Q2 | $1.03M | Hold |
2,845
| – | – | 0.33% | 23 |
|
|
2020
Q1 | $807K | Buy |
2,845
+260
| +10% | +$73.8K | 0.35% | 24 |
|
|
2019
Q4 | $840K | Hold |
2,585
| – | – | 0.27% | 30 |
|
|
2019
Q3 | $753K | Hold |
2,585
| – | – | 0.3% | 30 |
|
|
2019
Q2 | $759K | Hold |
2,585
| – | – | 0.35% | 30 |
|
|
2019
Q1 | $708K | Sell |
2,585
-510
| -16% | -$140K | 0.42% | 30 |
|
|
2018
Q4 | $693K | Buy |
+3,095
| New | +$693K | 0.47% | 29 |
|